Novavax
NVAX
#5781
Rank
โ‚ฌ0.95 B
Marketcap
5,85ย โ‚ฌ
Share price
3.45%
Change (1 day)
-29.38%
Change (1 year)

Earnings for Novavax (NVAX)

Earnings in 2025 (TTM): โ‚ฌ0.34 Billion

According to Novavax's latest financial reports the company's current earnings are โ‚ฌ1.02 Billion. In 2024 the company made an earning of -โ‚ฌ0.14 Billion, an increase over its 2023 earnings that were of -โ‚ฌ0.45 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Novavax from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚ฌ0.34 B-363.32%
2024 -โ‚ฌ0.14 Billion-70.39%
2023 -โ‚ฌ0.45 Billion-16.59%
2022 -โ‚ฌ0.54 Billion-62.58%
2021 -โ‚ฌ1.44 Billion320.54%
2020 -โ‚ฌ0.35 Billion234.22%
2019 -โ‚ฌ0.11 Billion-30.17%
2018 -โ‚ฌ0.15 Billion1.69%
2017 -โ‚ฌ0.15 Billion-36.44%
2016 -โ‚ฌ0.23 Billion70.4%
2015 -โ‚ฌ0.14 Billion89.27%
2014 -โ‚ฌ70.28 Million59.83%
2013 -โ‚ฌ43.97 Million81.9%
2012 -โ‚ฌ24.18 Million50.33%
2011 -โ‚ฌ16.08 Million
2009 -โ‚ฌ31.74 Million8.8%
2008 -โ‚ฌ29.17 Million18.01%
2007 -โ‚ฌ24.72 Million18.33%
2006 -โ‚ฌ20.89 Million168.31%
2005 -โ‚ฌ7.79 Million-62.51%
2004 -โ‚ฌ20.77 Million52.4%
2003 -โ‚ฌ13.63 Million-28.21%
2002 -โ‚ฌ18.98 Million
2000 -โ‚ฌ10.82 Million177%
1999 -โ‚ฌ3.91 Million-11.54%
1998 -โ‚ฌ4.42 Million10.64%
1997 -โ‚ฌ3.99 Million-9.62%
1996 -โ‚ฌ4.42 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Agenus
AGEN
โ‚ฌ17.53 M-94.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚ฌ0.22 Billion-167.25%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
โ‚ฌ0.14 B-55.92%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-โ‚ฌ5.62 Million-101.76%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚ฌ11.11 B 3,390.75%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
โ‚ฌ10.05 B 3,060.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
โ‚ฌ13.93 B 4,278.51%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NanoViricides
NNVC
-โ‚ฌ6.9 Million-102.17%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
โ‚ฌ7.91 B 2,386.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
-โ‚ฌ0.22 Billion-168.33%๐Ÿ‡บ๐Ÿ‡ธ USA